AIP
DXCM icon

Arrowpoint Investment Partners’s DexCom DXCM Stock Holding History

Arrowpoint Investment Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,000
Closed -$1.84M – 330
2025
Q1 		$1.84M Buy
+27,000
New +$2.2M 0.22% 102

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arrowpoint Investment Partners's DXCM Position: Q1 2026 in Review

Arrowpoint Investment Partners opened a new position in DexCom (DXCM) in Q1 2026: 3,628 shares worth $228K. The stake represents 0.2% of the portfolio and ranks #68 among its holdings. This is a return to the name: Arrowpoint Investment Partners previously reported a position in DXCM as recently as Q1 2025.

Arrowpoint Investment Partners first reported a position in DXCM in Q1 2025 and has held it in 2 quarters since. The position peaked at $1.6M in Q1 2025. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Arrowpoint Investment Partners held 3,628 shares of DexCom worth $228K as of Q1 2026.
  • DexCom was a new Arrowpoint Investment Partners position in Q1 2026.
  • DexCom made up 0.2% of Arrowpoint Investment Partners's portfolio in Q1 2026, its #68 holding.
  • Arrowpoint Investment Partners first reported a position in DexCom in Q1 2025 and has held it in 2 quarters since.
  • Arrowpoint Investment Partners's DexCom position peaked at $1.6M in Q1 2025.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.